Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rocket Pharmaceuticals Inc (NQ: RCKT )

55.58 USD +3.72 (+7.17%)
Official Closing Price Updated: 5:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Rocket Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial and... 
From Business Wire News Releases
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021
Upgrades According to Ladenburg Thalmann, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Neutral to Buy. ... 
Tags RCKT WFC TTNP
From Benzinga
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders announces participation at the... 
From Business Wire News Releases
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PRTA MSON XNCR
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings GRCL MORF
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 255 companies made new 52-week highs. Facts of Interest: The largest ... 
Tags VVV RJF WRAP
From Benzinga
Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the Company’s... 
From Business Wire News Releases
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags APLS Biotech SWAV
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 42.4% to $2.25 during Thursday's after-market session. SCWorx's trading ... 
Tags SLDB CERC Market News
From Benzinga
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Frazier Healthcare Partners announced the promotion of several members on its Life Sciences team: Aditya Kohli to Venture Partner, Anna Chen to Vice President, and Max Nowicki to Senior Associate. 
From Business Wire News Releases
Rocket Pharmaceuticals Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that... 
From Business Wire News Releases
Interesting RCKT Put And Call Options For February 2021
Investors in Rocket Pharmaceuticals Inc (RCKT) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the... 
From Business Wire News Releases
Rocket Pharmaceuticals Larger Than S&P 500 Component Under Armour
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Rocket Pharmaceuticals Inc (RCKT) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BEAM FDA ARWR
From Benzinga
Are These The Best Biotech Stocks To Buy In The Stock Market Today? 1 Up 420% In Two Days
From Stockmarket.com
Stocks That Hit 52-Week Highs On Thursday
This morning 90 companies reached new 52-week highs. Noteworthy Points: BHP Group (NYSE: BHP) was the biggest firm by ... 
Tags NVCR THC MRTX
From Benzinga
Thinking about trading options or stock in Rocket Pharmaceuticals, AstraZeneca, Virgin Galactic, General Motors, or Coca-Cola?
InvestorsObserver issues critical PriceWatch Alerts for RCKT, AZN, SPCE, GM, and KO. 
From PR Newswire
RCKT Crosses Above Average Analyst Target
In recent trading, shares of Rocket Pharmaceuticals Inc (RCKT) have crossed above the average analyst 12-month target price of $40.43, changing hands for $58.74/share. When a stock reaches the target... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BIIB PACB INFI
From Benzinga
71 Biggest Movers From Yesterday
Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares jumped 998.1% to close at $57.10 on Wednesday after the company reported ... 
Tags CATM Pre/Market Outlook Small Cap
From Benzinga
Stock Upgrades: Inotek Pharmaceuticals Shows Rising Relative Strength
Inotek Pharmaceuticals sees its Relative Strength Rating enter the elite 90-plus level. 
From Investor's Business Daily
Rocket Pharmaceuticals Prices Upsized Public Offering of Common Stock
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the... 
From Business Wire News Releases
These Biotech Stock Market Winners Have Nothing to Do With COVID-19
You don't have to be a pandemic fighter to have a big victory for investors. 
Tags RCKT ^DJI ^IXIC
From Motley Fool
Noteworthy Wednesday Option Activity: RCKT, CREE, DOCU
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rocket Pharmaceuticals Inc (RCKT), where a total of 4,102 contracts have traded so far,... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Nasdaq Tumbles 2%; DoorDash Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 0.56% to 30,005.91 while the NASDAQ fell 2.04% to 12,326.09. The S&P also ... 
Tags RCKT News Mid/Afternoon Market Update
From Benzinga
12 Healthcare Stocks Moving In Wednesday's Intraday Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock rose 352.99% to $23.55 during Wednesday's regular session. ... 
Tags Markets TLGT Intraday Update
From Benzinga
Mid-Day Market Update: Dow Drops Over 100 Points; Rocket Pharmaceuticals Shares Jump
Midway through trading Wednesday, the Dow traded down 0.37% to 30,061.07 while the NASDAQ fell 0.28% to 12,546.99. The S&P also ... 
Tags Market News Small Cap Eurozone
From Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares climbed 281.7% to $19.85 after the company reported data showing 0% ... 
Tags BDR WTRH OMI
From Benzinga
Why Rocket Pharmaceuticals's Stock is Trading Higher Today
The Price And Volume Action In Rocket Pharmaceuticals's Stock Today Rocket Pharmaceuticals (NASDAQ: RCKT) is currently up 73.77% ... 
Tags Movers BZ/WIIM Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.